Abilita Therapeutics
San Diego, US · Founded 2019 · 1 known investors
Abilita Therapeutics is a drug discovery company focused on membrane protein targets, using its EMP (Enabled Membrane Proteins) technology based on directed evolution to create stability- and expression-enhanced protein variants for discovering and optimizing drug candidates.
Founders & leadership
Abilita Therapeutics was founded in 2019 by Mauro Mileni.
MM
Mauro MileniinFounder & Chief Executive Officer
MR
Matthew RitterChief Business Officer
JS
Jim SchmidtChief Financial Officer
AA
Arshan AmiriGeneral Counsel
Investors · 1
Competitors · 4
by search overlapBioworld23 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
IQVIA21 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Alumis17 shared keywordsAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.
Eli Lilly17 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Companies competing with Abilita Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Abilita Therapeutics do?
- Abilita Therapeutics is a drug discovery company focused on membrane protein targets, using its EMP (Enabled Membrane Proteins) technology based on directed evolution to create stability- and expression-enhanced protein variants for discovering and optimizing drug candidates.
- Who founded Abilita Therapeutics?
- Abilita Therapeutics was founded by Mauro Mileni in 2019.
- Who are Abilita Therapeutics's investors?
- Abilita Therapeutics's investors include Two Bear Capital.
- Where is Abilita Therapeutics headquartered?
- Abilita Therapeutics is headquartered in San Diego, US.